Sector News

Gevo exploring strategic alternatives

June 1, 2016
Chemical Value Chain

Biobased isobutanol and ethanol producer Gevo (Englewood, CO) says it has commenced a review of strategic alternatives and has retained Cowen & Company as a financial advisor. The company did not say whether or not that included a potential sale of the company.

“After careful consideration, including discussions with a range of stakeholders, we believe it is an appropriate time to undertake a comprehensive review of the company’s strategic and financial alternatives,” says Ruth I. Dreessen, Chairman of the Board of Directors of Gevo. “The Board is thoroughly committed to exploring strategic and financial alternatives while simultaneously supporting management in the development of Gevo’s technology and business. We believe that pursuing both of these paths is in the best interests of all of our stakeholders, including our stockholders, and is expected to maximize the value of Gevo.”

The company is expecting to produce 750,000-1 million gallons of isobutanol and 15 million gallons of ethanol at its Luverne, MN facility in 2016. Ethanol margins have been breakeven to slightly negative, but are improving, the company reported last month.

By Rebecca Coons

Source: Chemical Week

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 23, 2021

Bayer AG appoints Sarena Lin as Chief Transformation and Talent Officer

Chemical Value Chain

Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.

January 23, 2021

Johnson Matthey’s battery plant in Poland to be powered by renewable electricity 

Chemical Value Chain

Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.

January 23, 2021

Oxford given £100m for antibiotic resistance research

Chemical Value Chain

Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.

Send this to a friend